Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
09/2005
09/08/2005US20050197384 water or organic solvent extract of mycelium of Antrodia Camphorata; has central cholinergic agonism, hepatoprotection, anti-inflammation or anti-tumor activity
09/08/2005US20050197349 Pyrrolo[2,3-D]pyrimidine compounds
09/08/2005US20050196554 Ink-receiving layer with light-fastness and photostability
09/08/2005DE102004006785A1 Verfahren zur CC-Bindungsknüpfung zwischen elektrophilen Substraten und TT-Verbindungen in neutralen bis basischen wässrigen oder alkoholischen Lösungsmitteln ohne den Einsatz einer Lewis- oder Protonensäure Process for carbon-carbon bond between electrophilic substrates and TT compounds in neutral to basic aqueous or alcoholic solvents without the use of a Lewis or protic acid
09/07/2005EP1569916A1 Substituted aralkyl derivatives
09/07/2005EP1569896A1 Tetrahydro-naphthalene derivatives
09/07/2005EP1569647A2 Cyclohexyl compounds as ccr5 antagonists
09/07/2005EP1569637A1 Bicyclic-substituted amines as histamine-3 receptor ligands
09/07/2005EP1347957B1 Delta 1-pyrrolines used as pesticides
09/07/2005EP1289953B1 Serine protease inhibitors
09/07/2005EP1192132B1 Serine protease inhibitors
09/07/2005EP1023308B1 Inhibitors of nucleoside metabolism
09/07/2005CN1665802A Bisarylsulfonamide compounds and their use in cancer therapy
09/07/2005CN1665785A 2-cyano-4-fluoropyrrolidine derivative or its salt
09/07/2005CN1665784A Peptide inhibitors of SMAC protein binding to inhibitor of apoptosis proteins (IAP)
09/07/2005CN1665475A Merocyanine derivatives for cosmetic use
09/07/2005CN1217932C Antibacterial agents
09/07/2005CN1217929C Amycomycin, production thereof and its use as pharmaceutical
09/07/2005CN1217928C Heterocyclic compounds having NOS inhibitory activities
09/07/2005CN1217918C Aminocyclohexyl ether compounds and uses thereof
09/06/2005US6939895 Renalosteodystrophy comprising a compound, or a pharmaceutically acceptable salt or hydrate thereof, having the formula: Ar5-(CHR16)t-W-(CH2)u-CHR17)-NH-CH(R18)-Ar6 wherein: Ar5 is phenyl, indole, carbazole, pyridine,
09/06/2005US6939891 Heterocyclic ureas, their preparation and their use as vanilloid receptor antagonists
09/06/2005US6939888 Heterocyclic amides such as 3-(2-chloro-6-methoxyphenyl)-5-isopropyl-5-methyl-4-acetoxy-3-pyrrolidine-2 -one, used as insecticides or miticides
09/01/2005WO2005080371A1 Amino heterocyclic modulators of chemokine receptor activity
09/01/2005WO2005080361A1 Histamine-3 receptor modulators
09/01/2005WO2005080328A1 Pyrrole-3-carboxamide derivatives for the treatment of obesity
09/01/2005WO2005080322A1 Fluorene derivative
09/01/2005WO2005080317A2 Therapeutic amide derivatives
09/01/2005WO2005080299A1 Novel monosulfonylated and carbonylated chiral compounds derived from a diamine or an aminoalcohol and carrying a pyrrolidinyl group, the preparation thereof, and the applications of the same in asymmetrical catalysis
09/01/2005WO2005080298A1 CATALYTIC ASYMMETRIC SYNTHESIS OF OPTICALLY ACTIVE α-HALO-CARBONYL COMPOUNDS
09/01/2005WO2005079863A1 Contrast medium for thrombus formation
09/01/2005WO2005079788A1 Amino alcohol compound
09/01/2005WO2005037772A3 Novel ligand activating receptors rars used for human medicine and cosmetics
09/01/2005WO2004085048A3 Production of 5-methyl-n-(methyl aryl)-2-pyrrolidone, 5-methyl-n-(methyl cycloalkyl)-2-pyrrolidone and 5- methyl-n-alkyl-2-pyrrolidone by reductive amination of leuvlinic acid esters with cyano compounds
09/01/2005US20050192441 Methods for the preparation of stereoisomerically enriched amines
09/01/2005US20050192313 Thio substituted with a hetero multiring group; sleepiness, promotion of wakefulness, Parkinson's disease, cerebral ischemia, stroke, sleep apneas, eating disorders, stimulation of appetite and weight gain, attention deficit hyperactivity disorder
09/01/2005US20050192292 Pyrrolidone carboxamides
09/01/2005US20050192291 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
09/01/2005US20050192286 Ligands of melanocortin receptors and compositions and methods related thereto
09/01/2005US20050192283 Fused-aryl and heteroaryl derivatives and methods of their use
09/01/2005US20050192208 Cardiovascular disorders; antiarrhythmia agents; sodium channel moderators ; potassium channel moderators; prevent fibrillation
09/01/2005US20050191567 Oxime ester photoinitiators
09/01/2005CA2559398A1 Pyrrole-3-carboxamide derivatives for the treatment of obesity
09/01/2005CA2558064A1 Contrast medium for thrombus formation
09/01/2005CA2555970A1 Therapeutic amide derivatives
09/01/2005CA2555073A1 Amino heterocyclic modulators of chemokine receptor activity
09/01/2005CA2555071A1 Histamine-3 receptor modulators
09/01/2005CA2554297A1 Catalytic asymmetric synthesis of optically active .alpha.-halo-carbonyl compounds
09/01/2005CA2537079A1 Fluorene derivative
08/2005
08/31/2005EP1568688A1 Therapeutic agent for respiratory disease containing 4-hydroxypiperidine derivative as active ingredient
08/31/2005EP1568686A1 n-alkylaminated secondary paraphenylendiamine, which is ortho- and/or meta-substituted, dying composition comprising this paraphenylendiamine, methods based on this composition and uses
08/31/2005EP1568683A2 Secondary, N-alkylaminated para-phenylenediamines, compositions for dyeing keratinic fibres containing them, processes using this compositions and uses thereof
08/31/2005EP1568355A1 N-alkylhydroxilated secondary paraphenylenediamine which is ortho- and/or meta substituted, composition for dying keratinous fibres comprising this paraphenylenediamine, methods based on this composition and uses.
08/31/2005EP1567518A2 Oxime ester photoinitiators with heteroaromatic groups
08/31/2005EP1567491A2 Compounds for inhibition of hiv infection by blocking hiv entry
08/31/2005EP1567490A2 Anti-sickling agents
08/31/2005EP1567489A1 Pyrrolidin-2-one derivatives as inhibitors of thrombin and factor xa
08/31/2005EP1567488A1 Hydroxyethylamine derivatives for the treatment of alzheimer's disease
08/31/2005EP1567487A2 Open chain prolyl urea-related modulators of androgen receptor function
08/31/2005EP1392288B1 Medicament containing an effector of the glutathione metabolism (ampbroxol) together with alpha-lipoic acid for treating diabetes mellitus
08/31/2005EP1278723B1 P-(sulfonyl)-aryl and -heteroaryl amines
08/31/2005EP1263773A4 Oligonucleotide analogues, methods of synthesis and methods of use
08/31/2005EP1140809B1 New biphenyl and biphenyl-analogous compounds as integrin antagonists
08/31/2005EP1095020B1 2-aminopyridine erivatives, their use as medicines and pharmaceutical compositions containing them
08/31/2005EP1073634B1 Method for producing enantiomerically pure n-methyl-n- (1s)-1-phenyl- 2-((3s)- 3-hydroxypyrrolidine- 1-yl)ethyl]- 2,2-diphenyl acetamide
08/31/2005CN1662530A Azabicyclo-octane and nonane derivatives with DPP-IV inhibiting activity
08/31/2005CN1662527A Pyrrolidinium derivatives as antagonists of M3 muscarinic receptors
08/31/2005CN1662521A Compounds useful for the treatment of obesity, type ii diabetes and cns disorders
08/31/2005CN1662514A Benzothiadiazepine derivatives, processes for their preparation and pharmaceutical compositions containing them
08/31/2005CN1660815A Cyclic amine derivatives and their use as drugs
08/31/2005CN1660805A Method for synthesizing 1-methyl-2-amine ethyl pyrrolidine
08/31/2005CN1216862C Method for processing pyrollidone and N-vinyl pyrollione residues
08/30/2005US6936729 Activation
08/30/2005US6936719 pyridine ring containing biaryl compound useful to treat and/or prevent clotting disorders, and as antiinflammatory and anticoagulant agents
08/30/2005US6936633 Pyrrolidinone derivatives
08/30/2005US6936626 Retinoic acid mimetic anilides
08/30/2005US6936611 Serine protease inhibitors
08/30/2005US6936077 1,3-diamino-4-(aminomethyl)—benzene derivatives and colorants containing the said compounds
08/25/2005WO2005077925A1 Sulfonylpyrrolodine modulators of androgen receptor fuction and method
08/25/2005WO2005077900A1 Bicyclic amide derivatives
08/25/2005WO2005077899A2 Amino-substituted tricyclic derivatives and methods of use
08/25/2005WO2005077898A1 Aryloxyalkylcarbamate-type derivatives, preparation method thereof and use of same in therapeutics
08/25/2005WO2005077895A1 Thioamides and salts thereof and cytokine production inhibitors containing both
08/25/2005WO2005077863A1 METHOD FOR ESTABLISHING CC BONDS BETWEEN ELECTROPHILIC SUBSTRATES AND π - NUCLEOPHILES IN NEUTRAL TO ALKALINE AQUEOUS OR ALCOHOLIC SOLVENTS WITHOUT USING A LEWIS OR BRONSTED ACID
08/25/2005WO2005077463A2 Ligand for a monoamine receptor or transporter for treating addiction or dependence
08/25/2005WO2005049590A3 N-sulfonylaminocarbonyl containing compounds
08/25/2005WO2004069394A3 Synthetic method for direct arylation of heterocyclic arenes
08/25/2005US20050187297 New compounds, methods for their preparation and use thereof
08/25/2005US20050187285 administering anticholesterol agents to inhibit the induction of major histocompatibilty complex (MHC class II) expression by gamma-inteferon (IFN- gamma); treatment of autoimmune diseases
08/25/2005US20050187284 Integrin receptor inhibitors
08/25/2005US20050187280 Furosemide modulators of HM74
08/25/2005US20050187272 Enzyme inhibitor on NO-synthase enzymes; treating STROKE, NEURODEGENERATIVE DISEASES, preventing ISCHEMIC OR HEMORRAGIC CARDIAC OR CEREBRAL INFARCTIONS; inhibiting lipidic peroxidation
08/25/2005US20050187267 Nonsteroidal, nontoxic tissue selective modulators for side effect reduction; age-related and androgen-receptor related conditions such as sarcopenia; e.g. 4-(4-Hydroxy-1,1,3-trioxohexahydrothia-2,6a-diazapentalen-2-yl)-2-chloro-3-methylbenzonitrile
08/25/2005US20050187261 For hepatitis C; histone deacetylase inhibitors, anticarcinogenic agents; N-hydroxy-4-{[(benzofuran-, benzothiophen-, or indol-)-2-ylcarbonylamino]alkoxy}benzamides; amidation of a benzoic acid, benzoate, benzoyl halide with hydroxyamine
08/25/2005US20050187251 Substituted N-heterocycle derivatives and methods of their use
08/25/2005US20050187205 Pyrrolidineacetamide derivative alone or in combination for treatment of CNS disorders
08/25/2005US20050187110 Novel herbicides
08/25/2005DE102004005787A1 Carboxamide Carboxamides
08/25/2005CA2555884A1 Amino-substituted tricyclic derivatives and methods of use
08/25/2005CA2554378A1 Bicycloamide derivative
1 ... 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 ... 404